I am a board certified physician-scientist with dual residency training in dermatology and nuclear medicine-molecular imaging. My clinical focus is on pigmented skin neoplasms including atypical moles (dysplastic nevi) and melanoma. My other clinical interests include non-melanoma skin cancers (e.g., basal cell carcinoma and squamous cell carcinoma), and consultative dermatology.
I have completed a fellowship at Memorial Sloan Kettering and the National Institutes of Health (NIH) in biophotonics with an emphasis on development of theranostics (probes that are both diagnostic and therapeutic) for skin cancer. My efforts led a joint MSK/NIH interdisciplinary translational project to develop a theranostic probe to molecularly target basal cell carcinoma (BCC). The goal of the project is to develop a non-invasive technology to molecularly image, diagnose, and treat BCC. If successful, this approach will also be applicable to other types of skin cancers. In my current dual capacity as a member of the Memorial Sloan Kettering faculty and an invited scientist at the NIH, my research efforts continue to focus on molecular imaging of skin cancer, with a recent emphasis on the use of nano-sized (less than 100 nanometers) probes to target biomarkers specific to cancer cells.